SG Americas Securities LLC Grows Holdings in Sabra Healthcare REIT, Inc. $SBRA

SG Americas Securities LLC grew its position in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 1,741.7% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 434,418 shares of the real estate investment trust’s stock after purchasing an additional 410,830 shares during the quarter. SG Americas Securities LLC owned approximately 0.18% of Sabra Healthcare REIT worth $8,011,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also recently modified their holdings of the company. Nuveen LLC bought a new position in Sabra Healthcare REIT in the 1st quarter worth $61,791,000. Bank of Montreal Can raised its holdings in Sabra Healthcare REIT by 244.1% during the second quarter. Bank of Montreal Can now owns 2,575,969 shares of the real estate investment trust’s stock valued at $47,501,000 after acquiring an additional 1,827,361 shares during the period. Jefferies Financial Group Inc. lifted its position in shares of Sabra Healthcare REIT by 7,196.8% in the first quarter. Jefferies Financial Group Inc. now owns 1,466,000 shares of the real estate investment trust’s stock valued at $25,611,000 after acquiring an additional 1,445,909 shares in the last quarter. Swedbank AB bought a new position in shares of Sabra Healthcare REIT in the first quarter worth about $19,336,000. Finally, VIRGINIA RETIREMENT SYSTEMS ET Al purchased a new stake in shares of Sabra Healthcare REIT during the second quarter worth about $7,048,000. 99.40% of the stock is currently owned by institutional investors.

Sabra Healthcare REIT Stock Down 0.2%

NASDAQ SBRA opened at $18.65 on Monday. The stock has a 50 day moving average price of $18.38 and a 200-day moving average price of $18.32. Sabra Healthcare REIT, Inc. has a one year low of $15.60 and a one year high of $19.97. The company has a debt-to-equity ratio of 0.91, a quick ratio of 4.80 and a current ratio of 4.80. The company has a market capitalization of $4.65 billion, a P/E ratio of 24.54, a P/E/G ratio of 1.10 and a beta of 0.84.

Sabra Healthcare REIT (NASDAQ:SBRA) last released its quarterly earnings results on Wednesday, November 5th. The real estate investment trust reported $0.38 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.37 by $0.01. Sabra Healthcare REIT had a net margin of 24.87% and a return on equity of 6.69%. The company had revenue of $190.04 million for the quarter, compared to the consensus estimate of $193.44 million. During the same quarter in the prior year, the firm earned $0.37 earnings per share. Sabra Healthcare REIT’s revenue was up 6.7% on a year-over-year basis. Sabra Healthcare REIT has set its FY 2025 guidance at 1.455-1.465 EPS. As a group, equities analysts predict that Sabra Healthcare REIT, Inc. will post 1.45 EPS for the current fiscal year.

Sabra Healthcare REIT Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, November 28th. Investors of record on Monday, November 17th will be given a $0.30 dividend. The ex-dividend date is Monday, November 17th. This represents a $1.20 annualized dividend and a yield of 6.4%. Sabra Healthcare REIT’s dividend payout ratio (DPR) is currently 166.67%.

Analysts Set New Price Targets

A number of research analysts recently commented on SBRA shares. Cantor Fitzgerald initiated coverage on Sabra Healthcare REIT in a report on Wednesday, October 1st. They issued a “neutral” rating and a $20.00 price target on the stock. Truist Financial lifted their price objective on shares of Sabra Healthcare REIT from $18.00 to $20.00 and gave the company a “hold” rating in a research report on Tuesday, September 2nd. National Bankshares set a $22.00 target price on shares of Sabra Healthcare REIT in a research report on Friday, October 17th. JMP Securities raised their target price on shares of Sabra Healthcare REIT from $20.00 to $22.00 and gave the company a “market outperform” rating in a research note on Wednesday, August 6th. Finally, Weiss Ratings reiterated a “buy (b)” rating on shares of Sabra Healthcare REIT in a research note on Wednesday, October 8th. One analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and five have given a Hold rating to the stock. According to data from MarketBeat, Sabra Healthcare REIT presently has a consensus rating of “Moderate Buy” and a consensus price target of $20.75.

Sabra Healthcare REIT Profile

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.